Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024



BOSTON, Jan. 11, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2024 financial results at 6:00 am ET on Thursday, February 8, 2024. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on February 8, 2024.

The call can be accessed via teleconference at: Q3 2024 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/unynzc8w 

A replay of the conference call and webcast will be available for one year beginning on February 8, 2024 at 11:00 am ET using the conference call webcast link provided in this press release.

About Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts: 


Olga Guyette, Sr. Director-Investor Relations & Treasury   


David Trenk, Manager-Investor Relations

(781) 356-9763     


(203) 733-4987





Media Contact: 


Josh Gitelson, Director-Global Communications


(781) 356-9776




Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-third-quarter-fiscal-year-2024-results-february-8-2024-302033140.html

SOURCE Haemonetics Corporation

Company Codes: NYSE:HAE

Back to news